Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients.
Jessica SeeßleJan LöhrMarietta KirchnerJosefin MichaelisUta MerlePublished in: BMC gastroenterology (2020)
For assessing hemostasis in Non-ACLF and ACLF patients the underlying dataset shows advantages of ROTEM over CCT. A10 and MCF represent suitable prognostic parameters in predicting bleeding events in ACLF group.